Medical Marijuana, Inc. Subsidiary Kannaway ® Welcomes Differentiated Sales and Marketing Expert Carolyn Dielmann Connolly as Brand Name Ambassador
Carolyn Dielmann Connolly, Kannaway ® Brand Name Ambassador
SAN DIEGO, July 30, 2020 (WORLD NEWSWIRE)– by means of NEWMEDIAWIRE– Medical Cannabis, Inc.( OTC: MJNA) (the “Company”), the first-ever publicly traded marijuana business in the United States that launched the world’s first-ever cannabis-derived nutraceutical items, brands and supply chain, announced today that its subsidiary Kannaway ® invites Carolyn Dielmann Connolly to the Company’s team of brand name ambassadors.
” Having seen all that Carolyn has achieved in her previous roles, I am humbled and delighted to have her sign up with Kannaway,” said Kannaway ® CEO Blake Schroeder. “We eagerly anticipate working along with her as she establishes her worldwide leadership team at Kannaway and assists us continue to reach new clients.”
Connolly has spent her networking career with a couple of widely known business and has developed a credibility as a leading money earner. In that function, she also became a National Licensed Trainer, Core Market Leader and Travel Committee Board Member. She has built, trained and led effective groups across the health and health sector of the mlm industry and developed leaders, systems and step-by-step programs to assist others succeed. Previously, she expanded her direct selling abilities while working with NuSkin International and serving in different sales and marketing positions throughout her profession.
“I have actually studied the CBD market carefully over the previous couple of years and wanted to get included since of the immense potential it has both in its ability to help numerous consumers and as a monetary chance,” stated Connolly. “I am positive in my ability to build a strong and passion-driven team around Kannaway’s strong worths and innovative offerings.”
Kannaway ® is a network sales and marketing business specializing in the sales and marketing of hemp-based botanical products. Kannaway ® currently hosts weekly online sales meetings and conferences throughout the United States, providing unique insight and opportunity to sales experts who are desirous of becoming effective leaders in the sale and marketing of hemp-based botanical products.
About Medical Cannabis, Inc.
We are a business of firsts ® Medical Marijuana, Inc. ( MJNA) is a cannabis business with 3 unique organisation units in the non-psychoactive cannabinoid area: a global portfolio of cannabinoid-based nutraceutical brand names led by Kannaway ® and HempMeds ®; a pioneer in sourcing the first-rate legal non-psychoactive marijuana products derived from commercial hemp; and a cannabinoid-based scientific research study and botanical drug development sector led by its pharmaceutical investment firm and partners consisting of AXIM ® Biotechnologies, Inc and Kannalife, Inc Medical Marijuana, Inc. was named a top CBD producer by CNBC Medical Marijuana, Inc. was likewise the first business to receive historical import allows for CBD items from the federal governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the advancement of international markets. The business’s flagship item Real Scientific Hemp Oil has actually been used in several effective medical research studies throughout Mexico and Brazil to understand its security and effectiveness.
Medical Marijuana, Inc.’s headquarters remains in San Diego, California, and extra details is offered at OTCMarkets.com or by going to www.medicalmarijuanainc.com To see Medical Cannabis, Inc.’s business video, click on this link
Investors and consumers are also encouraged to buy CBD oil and other items at Medical Marijuana, Inc.’s shop.
This news release may consist of certain forward-looking declarations and information, as defined within the meaning of Area 27 A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains declarations about predicted future events and/or monetary outcomes that are positive in nature and subject to dangers and uncertainties. Such forward-looking declarations by definition include risks, unpredictabilities and other aspects, which may trigger the real outcomes, efficiency or achievements of Medical Cannabis, Inc. to be materially various from the statements made herein.
FDA (FDA) DISCLOSURE
These declarations have not been assessed by the Food and Drug Administration. This product is not planned to diagnose, treat, treat, or avoid any disease.
Medical Cannabis, Inc. does not sell or disperse any products that are in violation of the United States Controlled Substances Act.
Investor Relations Contact:
P. (858) 283-4016